FAS and cancer: Additional evidence supporting the involvement of Fas pY in human cancer comes from our observation that pY291 Fas levels decreased while pY232 Fas levels increased in the majority of rectal tumors after radiotherapy (± concurrent chemotherapy, Fig 7D), suggesting distinct regulation and functions of pY232 and pY291 in Fas signaling in rectal cancer in response to cancer therapy.